Trial Status
Open for enrollment

What is the Purpose of this Study?
To evaluate whether Oxtellar XR reduces pain and improves the quality of life in patients with trigeminal neuralgia.

Who is Eligible to Participate?
Patients 18 to 75 diagnosed with trigeminal neuralgia and have a daily pain score of at least 4. Patients will also meet all inclusion criteria which will be explained in greater detail by the study coordinator.

What is involved in this Study?
Patients will take Oxtellar XR and titrate the dose over several days. The study consists of 4 office visits including lab work, questionnaires and exams.

How long is the Study?
The study is 12 weeks long.

For more information contact:
Lynette McKinney, MSCS, CRC, Study Coordinator at 602-358-2271 or lmckinney@pnal.net